4Daveau M, Scoffe M, Francois A, et al. Hepatocyte growth factor, transforming growth factor alpha,and their receptors as combined markers of prognosis in hepatocellular carcinoma [J]. Mol Carcinog, 2003,36(3):130-141.
5Moser GJ, Wolf DC,Goldsworthy TL. Quantitative relationship between transform ing growth factor-alpha and hepatic focalphenotype and progression in female mouse liver [J]. Toxicol Pathol, 1997,25 (3):275-283.
6Kira S, Nakanishi T, Sumori S, et al. Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma[J]. Liver, 1997,17(4):177-182.
7Decicco L A, Kong J, Ringer DP. Carcinogen-induced alteration in liver epidermal growth factor receptor distribution during the promotion stage of hepatocarcingenesis in rat[J].Cancer Len, 1997,111 (1-2):149-156.
8Vlahovic G, Crawford J. Activation of tyrosine kinases in cancer[J]. Oncologist, 2003,8(6):531-538.
9Kraizer Y, Mawasi N, Seagal J, et al. Vascular endothelial growth factor and angiopoietin in liver regeneration [J]. Biochem Biophys Res Commun, 2001,287 ( 1 ) :209-215.
10Zhao J, Hu J, Cai J, et al. Vascular endothelial growth factor expression in seFam of patients with hepatoeellular carcinoma[J]. Chin Med J(Engl ), 2003,116(5) :772-776.
